HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Abraira, C. Articles by Duckworth, W. Search for Related Content PubMed Articles by Abraira, C. Articles by Duckworth, W. Social Bookmarking                What's this?

The Need for Glycemic Trials in Type 2 Diabetes

In Brief

Glycemic control is a well-established treatment objective in diabetes care. However, the effectiveness and specific goals of glycemic control are not yet known for older type 2 diabetic patients with advanced complications and suboptimal response to current treatments. Therefore, current glycemic guidelines for such patients are variable. This article presents the rationale for ongoing long-term clinical trials to answer these questions and reviews the demonstrated effectiveness of hypertension and dyslipidemia control in reducing both microvascular and macrovascular complications.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				N. Emanuele, J. Sacks, R. Klein, D. Reda, R. Anderson, W. Duckworth, C. Abraira, and for the Veterans Affairs Diabetes Trial Group Ethnicity, Race, and Baseline Retinopathy Correlates in the Veterans Affairs Diabetes Trial Diabetes Care, August 1, 2005; 28(8): 1954 - 1958. [Abstract] [Full Text] [PDF]